Home Tags BioNTech

Tag: BioNTech

Vaccine Stocks: Another Pandemic Spike May be Ahead

The pandemic is getting out of hand. At the moment, about 160,000 Americans are testing positive for CV-19 every day – an increase of about...

The Top 4 Vaccine Stocks to Consider Immediately

The Tokyo Olympics may not happen. Just days ahead of the games, Japan is seeing a significant number of new cases, leading to calls to...

US FDA Says Moderna Vaccine is “Highly Effective”

Moderna (MRNA) just got a positive shot in the arm. All after the U.S. FDA said its vaccine is safe and effective in people ages...

US FDA Catalyst: The Top 3 Vaccine Stocks to Consider...

The pandemic is out of control. The world is up to 67 million cases, with 1.53 million unfortunate deaths.  In the U.S., the case count...

The Only Coronavirus Vaccine Stocks to Still Consider

We may be nearing a vaccine. Days ago, Pfizer and BioNTech said its vaccine had a 95% effective rate with no safety concerns.  “Efficacy was...

This is Why BioNTech is Still a Buy at $101

We’ve highlighted opportunity in BioNTech (BNTX) quite a few times. The first time was on May 5, as it traded at $48.50.  The most recent...

The Top 3 Vaccine Stocks to Consider Immediately

Pfizer (PFE) and BioNTech (BNTX) just said their vaccine is 95% effective against the coronavirus just days after saying it was 90% -- game-changing...

Moderna’s Vaccine Nearly 95% Effective Against Virus

Shares of Moderna (MRNA) are up nearly $10 a share this morning. All on news its vaccine is 94.5% effective against the coronavirus. Preliminary analysis of...

Five of the Top Ways to Trade Second Wave Pandemic Fear

The pandemic is a “humanitarian disaster,” as noted by CNN. And there’s no slowdown in sight. At the moment, the world is up to 52.2 million...

Top “Stay At Home” Stocks You May Want to Short, Near-Term

“Stay at home” stocks provided shelter from the pandemic for months. However, with blockbuster news that Pfizer’s clinical trial results suggest its vaccine could be...

Popular Post